578
Views
53
CrossRef citations to date
0
Altmetric
Research Article

Molecular Profiles of Parvalbumin-Immunoreactive Neurons in the Superior Temporal Cortex in Schizophrenia

, , , , , , , , , , , & show all
Pages 70-85 | Received 08 Oct 2013, Accepted 19 Dec 2013, Published online: 17 Mar 2014

REFERENCES

  • Ables, J. L., Breunig, J. J., Eisch, A. J., & Rakic, P. (2011). Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci, 12, 269–283.
  • Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., et al. (2006). Signaling across the synapse: A role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. J Cell Biol, 174, 127–139.
  • Anderson, M. F., Aberg, M. A., Nilsson, M., & Eriksson, P. S. (2002). Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res, 134, 115–122.
  • Behrens, M. M., & Sejnowski, T. J. (2009). Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?. Neuropharmacology, 57, 193–200.
  • Benes, F. M. (2011). Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropharmacology, 60, 1232–1242.
  • Benes, F. M., & Berretta, S. (2001). GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology, 25, 1–27.
  • Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry, 44, 88–97.
  • Benes, F. M., Lim, B., Matzilevich, D., Subburaju, S., & Walsh, J. P. (2008). Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci USA, 105, 20935–20940.
  • Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007). Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA, 104, 10164–10169.
  • Benes, F. M., McSparren, J., Bird, E. D., SanGiovanni, J. P., & Vincent, S. L. (1991). Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry, 48, 996–1001.
  • Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet, 17, 1156–1168.
  • Bitanihirwe, B. K., & Woo, T.-U. W. (2011). Oxidative stress in schizophrenia: An integrated approach. Neurosci Biobehav Rev, 35, 878–893.
  • Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., et al. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221–225.
  • Budnik, V., & Salinas, P. C. (2011). Wnt signaling during synaptic development and plasticity. Curr Opin Neurobiol, 21, 151–159.
  • Cabungcal, J. H., Nicolas, D., Kraftsik, R., Cuenod, M., Do, K. Q., & Hornung, J. P. (2006). Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia. Neurobiol Dis, 22, 624–637.
  • Cabungcal, J. H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013a). Early-life insults impair parvalbumin interneurons via oxidative stress: Reversal by N-acetylcysteine. Biol Psychiatry, 73, 574–582.
  • Cabungcal, J. H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., et al. (2013b). Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci USA, 110, 9130–9135.
  • Caricasole, A., Copani, A., Caruso, A., Caraci, F., Iacovelli, L., Sortino, M. A., et al. (2003). The Wnt pathway, cell-cycle activation and beta-amyloid: Novel therapeutic strategies in Alzheimer’s disease?. Trends Pharmacol Sci, 24, 233–238.
  • Carlson, M. E., Silva, H. S., & Conboy, I. M. (2008). Aging of signal transduction pathways, and pathology. Exp Cell Res, 314, 1951–1961.
  • Carro, E., Trejo, J. L., Nunez, A., & Torres-Aleman, I. (2003). Brain repair and neuroprotection by serum insulin-”like growth factor I. Mol Neurobiol, 27, 153–162.
  • Chen, J., Park, C. S., & Tang, S. J. (2006). Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem, 281, 11910–11916.
  • Chen, S., Guttridge, D. C., You, Z., Zhang, Z., Fribley, A., Mayo, M. W., et al. (2001). Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol, 152, 87–96.
  • Chun, K. S., & Langenbach, R. (2011). The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol Carcinog, 50, 439–448.
  • Ciani, L., Boyle, K. A., Dickins, E., Sahores, M., Anane, D., Lopes, D. M., et al. (2011). Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2)(+)/Calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A, 108, 10732–10737.
  • Conboy, L., Seymour, C. M., Monopoli, M. P., O’Sullivan, N. C., Murphy, K. J., & Regan, C. M. (2007). Notch signalling becomes transiently attenuated during long-term memory consolidation in adult Wistar rats. Neurobiol Learn Mem, 88, 342–351.
  • Copani, A., Uberti, D., Sortino, M. A., Bruno, V., Nicoletti, F., & Memo, M. (2001). Activation of cell-cycle-associated proteins in neuronal death: A mandatory or dispensable path?. Trends Neurosci, 24, 25–31.
  • Cuitino, L., Godoy, J. A., Farias, G. G., Couve, A., Bonansco, C., Fuenzalida, M., et al. (2010). Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. J Neurosci, 30, 8411–8420.
  • Curley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., et al. (2011). Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: Clinical, protein, and cell type-specific features. Am J Psychiatry, 168, 921–929.
  • Curley, A. A., & Lewis, D. A. (2012). Cortical basket cell dysfunction in schizophrenia. J Physiol, 590(Pt 4), 715–724.
  • Danesin, C., & Houart, C. (2012). A Fox stops the Wnt: Implications for forebrain development and diseases. Curr Opin Genet Dev, 22, 323–330.
  • Das, A. V., Bhattacharya, S., Zhao, X., Hegde, G., Mallya, K., Eudy, J. D., et al. (2008). The canonical Wnt pathway regulates retinal stem cells/progenitors in concert with Notch signaling. Dev Neurosci, 30, 389–409.
  • Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009). Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol, 19, 220–230.
  • Fan, Y., Abrahamsen, G., McGrath, J. J., & Mackay-Sim, A. (2012). Altered cell cycle dynamics in schizophrenia. Biol Psychiatry, 71, 129–135.
  • Freese, J. L., Pino, D., & Pleasure, S. J. (2010). Wnt signaling in development and disease. Neurobiol Dis, 38, 148–153.
  • Glausier, J. R., & Lewis, D. A. (2011). Selective pyramidal cell reduction of GABA(A) receptor alpha1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology, 36, 2103–2110.
  • Gogolla, N., Galimberti, I., Deguchi, Y., & Caroni, P. (2009). Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron, 62, 510–525.
  • Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010). Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep, 12, 335–344.
  • Guo, D., Ye, J., Dai, J., Li, L., Chen, F., Ma, D., et al. (2009). Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res, 33, 678–685.
  • Hall, A. C., Lucas, F. R., & Salinas, P. C. (2000). Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell, 100, 525–535.
  • Han, C., & Wu, T. (2005). Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem, 280, 24053–24063.
  • Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., et al. (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci, 23, 6315–6326.
  • Hayward, P., Brennan, K., Sanders, P., Balayo, T., DasGupta, R., Perrimon, N., et al. (2005). Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity. Development, 132, 1819–1830.
  • Homayoun, H., & Moghaddam, B. (2007). NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci, 27, 11496–11500.
  • Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci, 11, 77–86.
  • Ishitani, T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003). Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol, 23, 1379–1389.
  • Jensen, M., Brockie, P. J., & Maricq, A. V. (2012a). Wnt signaling regulates experience-dependent synaptic plasticity in the adult nervous system. Cell Cycle, 11, 2585–2586.
  • Jensen, M., Hoerndli, F. J., Brockie, P. J., Wang, R., Johnson, E., Maxfield, D., et al. (2012b). Wnt signaling regulates acetylcholine receptor translocation and synaptic plasticity in the adult nervous system. Cell, 149, 173–187.
  • Kaiya, H., Uematsu, M., Ofuji, M., Nishida, A., Takeuchi, K., Nozaki, M., et al. (1989). Elevated plasma prostaglandin E2 levels in schizophrenia. J Neural Transm, 77, 39–46.
  • Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 28, 27–30.
  • Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res, 38(Database issue), D355–D360.
  • Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., et al. (2006). From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res, 34(Database issue), D354–D357.
  • Katsel, P., Davis, K. L., Li, C., Tan, W., Greenstein, E., Kleiner Hoffman, L. B., et al. (2008). Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology, 33, 2993–3009.
  • Kaur, J., & Sanyal, S. N. (2010). PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: Chemoprevention by diclofenac. Tumour Biol, 31, 623–631.
  • Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006). A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci, 26, 1604–1615.
  • Kulak, A., Steullet, P., Cabungcal, J. H., Werge, T., Ingason, A., Cuenod, M., et al. (2013). Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: Insights from animal models. Antioxid Redox Signal, 18, 1428–1443.
  • Letamendia, A., Labbe, E., & Attisano, L. (2001). Transcriptional regulation by Smads: Crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am, 83-A Suppl 1(Pt 1), S31–S39.
  • Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2011). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci, 35, 57–67.
  • Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci, 35, 57–67.
  • Lewis, D. A., Hashimoto, T., & Morris, H. M. (2008). Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res, 14, 237–248.
  • Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci, 6, 312–324.
  • Ling, H., Sylvestre, J. R., & Jolicoeur, P. (2010). Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene, 29, 4543–4554.
  • Liodis, P., Denaxa, M., Grigoriou, M., Akufo-Addo, C., Yanagawa, Y., & Pachnis, V. (2007). Lhx6 activity is required for the normal migration and specification of cortical interneuron subtypes. J Neurosci, 27, 3078–3089.
  • Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., et al. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci, 31, 234–242.
  • Liu, D. X., & Greene, L. A. (2001). Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res, 305, 217–228.
  • Luzzi, V., Holtschlag, V., & Watson, M. A. (2001). Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol, 158, 2005–2010.
  • Mahadevappa, M., & Warrington, J. A. (1999). A high-density probe array sample preparation method using 10- to 100-fold fewer cells. Nat Biotechnol, 17, 1134–1136.
  • Malaterre, J., Ramsay, R. G., & Mantamadiotis, T. (2007). Wnt-Frizzled signalling and the many paths to neural development and adult brain homeostasis. Front Biosci, 12, 492–506.
  • Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004). Interneurons of the neocortical inhibitory system. Nat Rev Neurosci, 5, 793–807.
  • Martinez-Gras, I., Perez-Nievas, B. G., Garcia-Bueno, B., Madrigal, J. L., Andres-Esteban, E., Rodriguez-Jimenez, R., et al. (2011). The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. Schizophr Res, 128, 15–22.
  • Mason, H. A., Rakowiecki, S. M., Raftopoulou, M., Nery, S., Huang, Y., Gridley, T., et al. (2005). Notch signaling coordinates the patterning of striatal compartments. Development, 132, 4247–4258.
  • Miele, L., & Osborne, B. (1999). Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol, 181, 393–409.
  • Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., et al. (2012). MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A, 109, 3125–3130.
  • Miron, M., Woody, O. Z., Marcil, A., Murie, C., Sladek, R., & Nadon, R. (2006). A methodology for global validation of microarray experiments. BMC Bioinformatics, 7, 333.
  • Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., & Brzustowicz, L. M. (2011). Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry, 69, 188–193.
  • Muller, N. (2010). COX-2 inhibitors as antidepressants and antipsychotics: Clinical evidence. Curr Opin Investig Drugs, 11, 31–42.
  • Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., et al. (2011). GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology, 62, 1574–1583.
  • Neves, G., Shah, M. M., Liodis, P., Achimastou, A., Denaxa, M., Roalfe, G., et al. (2012). The LIM homeodomain protein Lhx6 regulates maturation of interneurons and network excitability in the mammalian cortex. Cereb Cortex. 23, 1811–1823.
  • Niehrs, C., & Acebron, S. P. (2012). Mitotic and mitogenic Wnt signalling. EMBO J, 31, 2705–2713.
  • Oishi, K., Kamakura, S., Isazawa, Y., Yoshimatsu, T., Kuida, K., Nakafuku, M., et al. (2004). Notch promotes survival of neural precursor cells via mechanisms distinct from those regulating neurogenesis. Dev Biol, 276, 172–184.
  • Park, D. S., Morris, E. J., Greene, L. A., & Geller, H. M. (1997). G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci, 17, 1256–1270.
  • Park, M., & Shen, K. (2012). WNTs in synapse formation and neuronal circuitry. EMBO J, 31, 2697–2704.
  • Pierri, J. N., Chaudry, A. S., Woo, T. U., & Lewis, D. A. (1999). Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry, 156, 1709–1719.
  • Pietersen, C. Y., Lim, M. P., Macey, L., Woo, T.-U. W., & Sonntag, K. C. (2011). Neuronal type-specific gene expression profiling and laser-capture microdissection. Methods Mol Biol, 755, 327–343.
  • Pietersen, C. Y., Lim, M. P., & Woo, T.-U. W. (2009). Obtaining high quality RNA from single cell populations in human postmortem brain tissue. J Vis Exp, 30.
  • Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2011). Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology, 62, 1322–1331.
  • Rodriguez, D. A., Tapia, J. C., Fernandez, J. G., Torres, V. A., Munoz, N., Galleguillos, D., et al. (2009). Caveolin- 1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol Biol Cell, 20, 2297–2310.
  • Sahores, M., & Salinas, P. C. (2011). Activity-mediated synapse formation a role for Wnt-Fz signaling. Curr Top Dev Biol, 97, 119–136.
  • Santarelli, D. M., Beveridge, N. J., Tooney, P. A., & Cairns, M. J. (2011). Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry, 69, 180–187.
  • Selemon, L. D., & Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry, 45, 17–25.
  • Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., et al. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A, 96, 5522–5527.
  • Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., et al. (2009). Gene expression profiling of substantia nigra dopamine neurons: Further insights into Parkinson’s disease pathology. Brain, 132(Pt 7), 1795–1809.
  • Singer, W., Gray, C., Engel, A., Konig, P., Artola, A., & Brocher, S. (1990). Formation of cortical cell assemblies. Cold Spring Harb Symp Quant Biol, 55, 939–952.
  • Soltesz, I. (2005). Diversity in the neuronal machine. New York: Oxford University Press.
  • Spencer, K. M. (2009). The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: Insights from computational modeling. Front Hum Neurosci, 3, 33.
  • Spencer, K. M., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., et al. (2004). Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A, 101, 17288–17293.
  • Steullet, P., Neijt, H. C., Cuenod, M., & Do, K. Q. (2006). Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia. Neuroscience, 137, 807–819.
  • Tiberi, L., Vanderhaeghen, P., & van den Ameele, J. (2012). Cortical neurogenesis and morphogens: Diversity of cues, sources and functions. Curr Opin Cell Biol, 24, 269–276.
  • Uhlhaas, P. J., Pipa, G., Lima, B., Melloni, L., Neuenschwander, S., Nikolic, D., et al. (2009). Neural synchrony in cortical networks: History, concept and current status. Front Integr Neurosci, 3, 17.
  • Uhlhaas, P. J., & Singer, W. (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci, 11, 100–113.
  • Wang, L., Lockstone, H. E., Guest, P. C., Levin, Y., Palotas, A., Pietsch, S., et al. (2010). Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res, 9, 521–527.
  • Wang, X. J. (2010). Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev, 90, 1195–1268.
  • Wang, Y., Chan, S. L., Miele, L., Yao, P. J., Mackes, J., Ingram, D. K., et al. (2004). Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci U S A, 101, 9458–9462.
  • Woo, T. U. W., Miller, J. L., & Lewis, D. A. (1997). Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry, 154, 1013–1015.
  • Woo, T. U. W., Spencer, K., & McCarley, R. W. (2010). Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv Rev Psychiatry, 18, 173–189.
  • Woo, T. U. W., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998). A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A, 95, 5341–5346.
  • Yang, X., Klein, R., Tian, X., Cheng, H. T., Kopan, R., & Shen, J. (2004). Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol, 269, 81–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.